期刊文献+

ERK5和JNK参与BMP9诱导的C3H10T1/2细胞向心肌样细胞分化 被引量:4

Involvement of ERK5 and JNK in the BMP9-induced differentiation of C3H10T1/2 cells into cardiomyocyte-like cells
下载PDF
导出
摘要 目的研究细胞外信号调节激酶5(ERK5)和c-Jun N端激酶(JNK)在骨形态发生蛋白9(BMP9)诱导的C3H10T1/2细胞向心肌样细胞分化中的作用。方法利用重组腺病毒将BMP9基因导入C3H10T1/2细胞,Western blot法检测加入BMP9及不同浓度ERK5特异性抑制剂BIX02189或JNK特异性抑制剂SP600125后ERK5和JNK的激活情况;实时定量PCR(qRT-PCR)检测BMP9诱导1周后心肌特异性基因肌细胞增强因子2C(MEF2C)、GATA结合蛋白4(GATA4)表达;Western blot法检测经BMP9诱导3周后心肌特异性蛋白缝隙连接蛋白43(CX43)、心肌肌钙蛋白T(cTnT)表达和免疫荧光技术检测CX43、cTnT在细胞内的表达。结果在转染效率达50%左右的情况下,BMP9可过度激活ERK5和JNK,使其磷酸化水平显著增高(P<0.05);BIX02189抑制ERK5激活后,BMP9诱导的C3H10T1/2细胞的心肌分化标志物MEF2C、GATA4、CX43、cTnT均受到显著抑制(P<0.05),JNK特异性抑制剂SP600125也可抑制MEF2C、GATA4、CX43、cTnT表达,但对MEF2C及GATA4的抑制不如BIX02189显著(P<0.05)。结论 ERK5和JNK的过度激活参与了BMP9诱导的C3H10T1/2细胞向心肌样细胞的分化。 Objective To investigate the roles of extracellular signal-regulated kinase 5 (ERKS) and c-Jun N-terminal kinase (JNK) in the differentiation of C3H10T1/2 cells into cardiomyocyte-like cells induced by bone morphogenetic protein 9 (BMPg). Methods BMP9 gene was imported into C3H10T1/2 cells by recombinant adenovirus. Western blotting was used to detect the actived levels of ERK5 and JNK after cultivated with BMP9 and different concentrations of ERK5 specific inhibitor BIX02189 or JNK specific inhibitor SP600125; real-time quantitative PCR (qRT-PCR) was performed to analyze the expressions of myocardium specific genes GATA binding protein 4 ( GATA4), myocyte enhancer factor 2C (MEF2C) after one week induced by BMP9; Western blotting was conducted to measure the expressions of myocardium specific proteins connexin 43 (CX43), cardiac troponin T (cTnT) after three weeks induced by BMPg, and immunofluorescence to observe the positions of CX43 and cTnT in the cells. Results In the case of transfection efficiency up to 50%, BMP9 exceedingly activated ERK5 and JNK, and significantly increased their phosphorylation level (P 〈 0.05 ). After BIX02189 inhibited the activity of ERKS, the expression levels of myocardial differentiation markers MEF2C, GATA4, CX43, cTnT of C3H10T1/2 cells were significantly suppressed (P 〈 0.05 ); JNK specific inhibitor SP600125 also inhibited the expression levels of MEF2C, GATA4, CX43, cTnT, but the inhibition on MEF2C and GATA4 was not as notable as that of BIX02189 (P〈0.05). Conclusion The excessive activation of ERK5 and JNK plays an important role in the differentiation of C3H10T1/2 cells into cardiomyocyte-like cells induced by BMP9.
出处 《细胞与分子免疫学杂志》 CAS CSCD 北大核心 2014年第8期829-832,840,共5页 Chinese Journal of Cellular and Molecular Immunology
基金 国家自然科学基金(30772361)
关键词 细胞外信号调节激酶5 C-JUN N端激酶 骨形态发生蛋白9 心肌样细胞 肌细胞增强因子2C extracellular signal-regulated kinaseS c-Jun N-terminal Idnase bone morphogenetic protein 9 cardiomyocyte-like cell myocyte enhancer factor 2C
  • 相关文献

参考文献13

  • 1Elnakish MT, Hassan F, Dakhlallah D, et al. Mesenchynml stem cells for cardiac regeneration : translation to bedside reality [ J/OL ]. Stem Cells Int, 2012, 2012:6460381.
  • 2Reznikoff CA, Brankow DW, Heidelberger C. Establishment and characterization of a cloned line of C3H mouse embryo cells sensitive to postconfluence inhibition of division [ J ]. Cancer Res, 1973, 33 (12) : 3231 - 3238.
  • 3Wang J, Greene SB, Martin JF. BMP signaling in congenital heart disease: new developments and future directions [ J ]. Birth Defects Res A Clin Mol Teratol, 2011, 91(6) : 441 -448.
  • 4谭金童,陈沅,向平.BMP_9对C_3H10T_(1/2)干细胞向心肌样细胞分化的影响[J].重庆医科大学学报,2009,34(6):672-676. 被引量:10
  • 5张芬,陈沅,孙文静,陈露,陈妙月,朱高慧.P^(38)MAPK通路在BMP9诱导C3H10T1/2干细胞向心肌样细胞分化中的作用[J].重庆医科大学学报,2012,37(8):657-660. 被引量:3
  • 6Miyazono K, Kamiya Y, Morikawa M. Bone morphogenetic protein receptors and signal transduction[ J]. J Biochem, 2010, 147 (1) : 35 -51.
  • 7Peti W, Page R. Molecular basis of MAP kinase regulation [ J ]. Protein Sci, 2013, 22(12) : 1698 -1710.
  • 8Nithianandarajah-Jones GN, Wilm B, Goldring CE, et al. ERK5:Structure, regulation and function [ J ]. Cell Signal, 2012, 24 ( 11 ) 2187 -2196.
  • 9Bogoyevitch MA, Ngoei KR, Zhao TT, et al. c-Jun N-terminal kinase ( JNK ) signaling: recent advances and challenges [ J ]. Biochim Biophys Acta, 2010, 1804(3) : 463 -475.
  • 10Tatake RJ, O'Neill MM, Kennedy CA, et al. Identification af phrmacological inhibitors of the MEK5/ERK5 pathway [ J ]. Biochem Biophys Res Commun, 2008, 377(1): 120-125.

二级参考文献25

  • 1张雷,吴文成,邵素霞,赵春芳.猴左心室乳头肌工作心肌细胞间闰盘的立体结构与发育[J].电子显微学报,2003,22(6):461-462. 被引量:5
  • 2张文,田杰,江德勤,张蕾,朱静,陈沅.骨髓间充质干细胞体外分化为心肌样细胞相关调控基因的时序表达[J].中华心血管病杂志,2004,32(11):1004-1008. 被引量:25
  • 3崔凯,张军,李宝丰,郭国桢.电磁脉冲照射前后大鼠心肌超声背向散射参数变化的研究[J].心脏杂志,2006,18(3):293-295. 被引量:5
  • 4Joong-Yeon Lim,Won Ho Kim,Joon Kim,et al.Involvement of TC F-β 1 signaling in cardiomyocyte differentiation from P19CL6 Cells[J].Mol.Cells,2007,24(3):431-436.
  • 5Waiters M J,Wayman G A,Christian J I,.Bone morphogenetic protein function is required for terminal differentiation of the heart but not for early expression of cardiac marker genes[J].Mech Dev,2001,100(2):263-273.
  • 6Varga A C,Wrana J L.The disparate role of BMP in stem cell biology[J].Oncogene,2005,24(37):5713-5721.
  • 7Makino S,Fukuda K,Miyoshi S,et al.Cardiomyocytes can be generated from marrow sternal cells in vitre[J].J Clin Invest,1999,103(5):697-705.
  • 8Ishida W,Itamamoto T,Kusanagi K,et al.Stood6 is a Smad1/5-induced smad inhibitor.Characterization of bone morphogenetic protein-responsive element in the mouse Smad6 promoter[J].J Biol Chem,2000,275(9):6075-6079.
  • 9GrepinC,Nmer G,Nemer M.Enhanced cardiogenesis in embryonic stem cell overexpressing the GATA-4 transcription factor[J].Development,1997,124(12):2387-2395.
  • 10Davidson SM,Marange M.Hsp25 and the p38 MAPK pathway are involved in differentiation of cardiomyocytes[J].Dev Biol.,2000,218 (2):146-160.

共引文献9

同被引文献36

  • 1Rogelio Zamilpa,Mary M Navarro,Iris Flores,Sy Griffey.Stem cell mechanisms during left ventricular remodeling post-myocardial infarction:Repair and regeneration[J].World Journal of Cardiology,2014,6(7):610-620. 被引量:11
  • 2赵金东,吕松岑,薛震,邓秋奎.激素性股骨头坏死动物模型的建立与评价[J].中国骨肿瘤骨病,2007,6(4):220-225. 被引量:14
  • 3Noiseux N, Marquis-Gravel G, Mansour S, et al. The current state of stern cell therapeutics: Canadian approaches in the international context[J]. Can J Cardiol, 2014, 30( 11 ) : 1361 - 1369.
  • 4Grinstein J, Burkhoff D. Innovative devices for advanced heart failure: exploring the current state and future direction of device therapies[J]. Curr Opin Cardiol, 2015, 30(3) : 267 -276.
  • 5Poglajen G, Vrtovec B. Stem cell therapy for chronic heart failure [J]. Curr Opin Cardiul, 2015, 30(3) : 301 -310.
  • 6Aguirre A, Sancho-Martinez I, Izpisua Belmonte JC. Reprogramming toward heart regeneration: stem cells and beyond [ J ]. Cell Stem Ceil, 2013, 12(3) : 275 -284.
  • 7Eckertma MA, Vu Q, Xie K, et al. Evidence for high translational potential of mesenchymal stromal cell therapy to improve recovery from ischemic stroke[J]. J Cereb Blood Flow Metab, 2013, 33(9) : 1322 - 1334.
  • 8Beane OS, Darling EM. Isolation, characterization, and differentiation of stem cells for cartilage regeneration[J]. Ann Biomed Eng, 2012, 40(10) : 2079 -2097.
  • 9Karantalis V, Hare JM. Use of mesenchymal stem cells for therapy of cardiac disease[J]. Circ Res, 2015, 116(8): 1413-1430.
  • 10Karam JP, Bonafe F, Sindji L, et al. Adipose-derived stem cell adhesion on laminin-coated micmcarriers improves commitment toward the cardiomyogenic lineage [ J ]. J Biomed Mater Res A, 2015, 103(5): 1828-1839.

引证文献4

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部